Literature DB >> 23029747

Case of Cronkhite Canada syndrome shows improvement with enteral supplements.

S P Lipin1, Baby Paul, E Nazimudeen, Baiju Sam Jacob.   

Abstract

Cronkhite-Canada syndrome (CCS) is a rare nonfamilial syndrome characterized by marked epithelial disturbances in the GI tract and epidermis. Cronkhite and Canada described the first 2 cases in 1955. Since then only about 450 cases have been reported worldwide. Here we report a 33 year old Indian male admitted with history of loose stools and abdominal pain, loose stools associated with weight loss, generalized weakness, significant amount of hair loss as well as hyperpigmentation of his palms and soles. On subsequent days of the stay in the hospital he developed hypogeusia and showed onychodystrophy. Endoscopy of Upper GI and Lower GI tract revealed severe gastroduodenitis with polyp in duodenum and multiple polyps whole throughout the colon respectively. Biopsy report showed eosinophilic gastritis and hamartomatous polyps in colon as well as in duodenum. He was started on high protein supplement, proton pump inhibitors and zinc-vitamin supplement and he showed a complete recovery in symptoms within 5 months of initiation of treatment. Hence, early diagnosis and initiation of appropriate treatment helped the patient to improve in symptoms from such a rare disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23029747

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  3 in total

1.  Cronkhite-Canada Syndrome: Sustained Clinical Response with Anti-TNF Therapy.

Authors:  S A Taylor; J Kelly; D E Loomes
Journal:  Case Rep Med       Date:  2018-07-02

Review 2.  Cronkhite-Canada syndrome: review of the literature.

Authors:  Marcela Kopáčová; Ondřej Urban; Jiří Cyrany; Jan Laco; Jan Bureš; Stanislav Rejchrt; Jolana Bártová; Ilja Tachecí
Journal:  Gastroenterol Res Pract       Date:  2013-11-28       Impact factor: 2.260

3.  Cases Report the Cronkhite-Canada Syndrome: Improving the Prognosis.

Authors:  Yi Qun Yu; Peter James Whorwell; Lin Heng Wang; Jun Xiang Li; Qing Chang; Jie Meng
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.